Infinitum Asset Management, LLC Sarepta Therapeutics, Inc. Transaction History
Infinitum Asset Management, LLC
- $452 Billion
- Q2 2025
A detailed history of Infinitum Asset Management, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Infinitum Asset Management, LLC holds 1,000 shares of SRPT stock, worth $23,120. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,000Holding current value
$23,120% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding SRPT
# of Institutions
462Shares Held
82.5MCall Options Held
5.6MPut Options Held
4.19M-
Black Rock Inc. New York, NY10.3MShares$239 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.16MShares$212 Million0.0% of portfolio
-
State Street Corp Boston, MA4.7MShares$109 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY4.48MShares$104 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA2.53MShares$58.5 Million0.01% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $2.02B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...